Vast medical studies indicate that approximately 3% of the population is prone to developing a brain aneurysm during their lifetime. This results in hundreds of thousands of victims worldwide each year, creating a significant annual economic burden exceeding $10 billion in the U.S. alone.

The primary concern with aneurysms is the potential for rupture, which often leads to a massive, traumatic hemorrhagic event, leaving little to no chance for the brain to recover. While most aneurysms do not rupture, those that do result in devastating outcomes. To put this into perspective, 25% of individuals will not survive the rupture and will die immediately, while another 25% will succumb within six weeks. The remaining survivors often suffer from moderate to severe neurological disorders, contributing to significant morbidity and mortality.

Currently, no medical examination can predict or classify an individual's risk of developing an aneurysm. Since aneurysm formation typically occurs without symptoms, affected individuals remain unaware of the ticking time bomb within them until it reaches the point of no return and ruptures. Most aneurysms grow over time, increasing the risk of rupture. Only the "lucky ones" who undergo brain imaging scans that include vascular visualization have a chance of being diagnosed with an existing aneurysm and receiving timely intervention. Once an aneurysm is detected, follow-up assessments are scheduled to monitor its growth rate and determine whether intervention is necessary to prevent rupture.

This is where Aneuscreen provides the ultimate solution. Aneuscreen offers a revolutionary, once-in-a-lifetime, cost-effective, and highly accurate diagnostic exam designed to predict the future formation of intracranial aneurysms. Supporting all angiographic brain imaging scans, our proprietary, patented algorithm analyzes the entire vascular configuration, assessing the morphological characteristics of the brain’s arterial tree. This allows us to determine whether an individual is at risk and requires monitoring.

Additionally, our solution empowers neuroradiologists to detect small aneurysms (less than 3mm in diameter) by highlighting locations along the arteries that are prone to aneurysm development. These small aneurysms are often overlooked due to their size, leaving patients unaware of their existence and vulnerable to future rupture.

With Aneuscreen, early detection and intervention become possible, ultimately saving lives and reducing the burden of aneurysmal disease.